clinical trial · NCT00651807
A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
Organon and Co·phase2·terminated·n = 16
Benign Prostatic Hyperplasia (BPH)etonogestrelPlacebo
brief summary
This trial is conducted to evaluate the effect of etonogestrel in comparison to placebo on: * the prostate volume and the urinary complaints; * the urinary flow and the urinary volume in the bladder after voiding; * the progression of the disease; * the sexual function, well-being and urinary complaints-related Quality of Life. In addition the safety and the way the drug is absorbed and excreted by the body will be analyzed.
started
Mar 1, 2008
primary completion
Aug 1, 2008
completion
Aug 1, 2008
last updated
Apr 8, 2026
official title
Phase II, Randomized, Double-Blind, Placebo-Controlled Trial Investigating the Efficacy and Safety of Org 3236 Tablets in Men With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia (BPH)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol